No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Contineum Starts Patient Dosing in Positron Emission Tomography Trial
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
Express News | Contineum Therapeutics Inc - Expects $213.9 Mln Cash to Fund Operations Through 2027
Express News | Contineum Therapeutics Inc - Phase 1B Study for Pipe-791 to Begin in Q1 2025
Unlock the Full List